UCL dividend yield: 4.00%. PFE dividend yield: 6.77%. UCL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in UCL shares. Pfizer offers one of the highest dividend yields among blue-chip pharma companies. Post-COVID revenue normalization has pressured earnings, but the dividend has been maintained. Pfizer's acquisition of Seagen adds oncology depth. With 14+ consecutive years of no dividend cuts, income investors see the high yield as an opportunity.
UCL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in UCL shares.
Pfizer offers one of the highest dividend yields among blue-chip pharma companies. Post-COVID revenue normalization has pressured earnings, but the dividend has been maintained. Pfizer's acquisition of Seagen adds oncology depth. With 14+ consecutive years of no dividend cuts, income investors see the high yield as an opportunity.
UCL currently offers a 4.00% yield (2.00/share/year) while PFE offers 6.77% (1.68/share/year). PFE provides higher current income. However, UCL has grown its dividend faster (5% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in UCL vs PFE earn per year?
With $10,000 invested today: UCL pays approximately $400/year. PFE pays approximately $677/year. With DRIP reinvestment over 10 years, these grow to $899/year (UCL) and $5,820/year (PFE).
Does UCL or PFE pay monthly dividends?
UCL pays quarterly dividends. PFE pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this UCL vs PFE comparison by email
Save your analysis + get weekly dividend insights. Free forever.